A compendium of volatile organic compounds (VOCs) released by human cell lines

Wojciech Filipiak, Pawel Mochalski, Anna Filipiak, Clemens Ager, Raquel Cumeras, Cristina E Davis, Agapios Agapiou, Karl Unterkofler, Jakob Troppmair

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

Volatile organic compounds (VOCs) offer unique insights into ongoing biochemical processes in healthy and diseased humans. Yet, their diagnostic use is hampered by the limited understanding of their biochemical or cellular origin and their frequently unclear link to the underlying diseases. Major advancements are expected from the analyses of human primary cells, cell lines and cultures of microorganisms. In this review, a database of 125 reliably identified VOCs previously reported for human healthy and diseased cells was assembled and their potential origin is discussed. The majority of them have also been observed in studies with other human matrices (breath, urine, saliva, feces, blood, skin emanations). Moreover, continuing improvements of qualitative and quantitative analyses, based on the recommendations of the ISO-11843 guidelines, are suggested for the necessary standardization of analytical procedures and better comparability of results. The data provided contribute to arriving at a more complete human volatilome and suggest potential volatile biomarkers for future validation.

Original languageEnglish (US)
Pages (from-to)2112-2131
Number of pages20
JournalCurrent Medicinal Chemistry
Volume23
Issue number20
DOIs
StatePublished - Jun 1 2016

Fingerprint

Volatile Organic Compounds
Cells
Cell Line
Biomarkers
Cell culture
Microorganisms
Standardization
Skin
Blood
Biochemical Phenomena
Saliva
Feces
Cell Culture Techniques
Urine
Databases
Guidelines

Keywords

  • Biomarker
  • Breath analysis
  • Cancer
  • GC-MS
  • Human cell lines
  • Standardization
  • Volatile organic compounds (VOCS)
  • Volatilome

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Filipiak, W., Mochalski, P., Filipiak, A., Ager, C., Cumeras, R., Davis, C. E., ... Troppmair, J. (2016). A compendium of volatile organic compounds (VOCs) released by human cell lines. Current Medicinal Chemistry, 23(20), 2112-2131. https://doi.org/10.2174/092986732366616031612505

A compendium of volatile organic compounds (VOCs) released by human cell lines. / Filipiak, Wojciech; Mochalski, Pawel; Filipiak, Anna; Ager, Clemens; Cumeras, Raquel; Davis, Cristina E; Agapiou, Agapios; Unterkofler, Karl; Troppmair, Jakob.

In: Current Medicinal Chemistry, Vol. 23, No. 20, 01.06.2016, p. 2112-2131.

Research output: Contribution to journalReview article

Filipiak, W, Mochalski, P, Filipiak, A, Ager, C, Cumeras, R, Davis, CE, Agapiou, A, Unterkofler, K & Troppmair, J 2016, 'A compendium of volatile organic compounds (VOCs) released by human cell lines', Current Medicinal Chemistry, vol. 23, no. 20, pp. 2112-2131. https://doi.org/10.2174/092986732366616031612505
Filipiak, Wojciech ; Mochalski, Pawel ; Filipiak, Anna ; Ager, Clemens ; Cumeras, Raquel ; Davis, Cristina E ; Agapiou, Agapios ; Unterkofler, Karl ; Troppmair, Jakob. / A compendium of volatile organic compounds (VOCs) released by human cell lines. In: Current Medicinal Chemistry. 2016 ; Vol. 23, No. 20. pp. 2112-2131.
@article{a11bd5ab01b0401890279b10d3e1e424,
title = "A compendium of volatile organic compounds (VOCs) released by human cell lines",
abstract = "Volatile organic compounds (VOCs) offer unique insights into ongoing biochemical processes in healthy and diseased humans. Yet, their diagnostic use is hampered by the limited understanding of their biochemical or cellular origin and their frequently unclear link to the underlying diseases. Major advancements are expected from the analyses of human primary cells, cell lines and cultures of microorganisms. In this review, a database of 125 reliably identified VOCs previously reported for human healthy and diseased cells was assembled and their potential origin is discussed. The majority of them have also been observed in studies with other human matrices (breath, urine, saliva, feces, blood, skin emanations). Moreover, continuing improvements of qualitative and quantitative analyses, based on the recommendations of the ISO-11843 guidelines, are suggested for the necessary standardization of analytical procedures and better comparability of results. The data provided contribute to arriving at a more complete human volatilome and suggest potential volatile biomarkers for future validation.",
keywords = "Biomarker, Breath analysis, Cancer, GC-MS, Human cell lines, Standardization, Volatile organic compounds (VOCS), Volatilome",
author = "Wojciech Filipiak and Pawel Mochalski and Anna Filipiak and Clemens Ager and Raquel Cumeras and Davis, {Cristina E} and Agapios Agapiou and Karl Unterkofler and Jakob Troppmair",
year = "2016",
month = "6",
day = "1",
doi = "10.2174/092986732366616031612505",
language = "English (US)",
volume = "23",
pages = "2112--2131",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "20",

}

TY - JOUR

T1 - A compendium of volatile organic compounds (VOCs) released by human cell lines

AU - Filipiak, Wojciech

AU - Mochalski, Pawel

AU - Filipiak, Anna

AU - Ager, Clemens

AU - Cumeras, Raquel

AU - Davis, Cristina E

AU - Agapiou, Agapios

AU - Unterkofler, Karl

AU - Troppmair, Jakob

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Volatile organic compounds (VOCs) offer unique insights into ongoing biochemical processes in healthy and diseased humans. Yet, their diagnostic use is hampered by the limited understanding of their biochemical or cellular origin and their frequently unclear link to the underlying diseases. Major advancements are expected from the analyses of human primary cells, cell lines and cultures of microorganisms. In this review, a database of 125 reliably identified VOCs previously reported for human healthy and diseased cells was assembled and their potential origin is discussed. The majority of them have also been observed in studies with other human matrices (breath, urine, saliva, feces, blood, skin emanations). Moreover, continuing improvements of qualitative and quantitative analyses, based on the recommendations of the ISO-11843 guidelines, are suggested for the necessary standardization of analytical procedures and better comparability of results. The data provided contribute to arriving at a more complete human volatilome and suggest potential volatile biomarkers for future validation.

AB - Volatile organic compounds (VOCs) offer unique insights into ongoing biochemical processes in healthy and diseased humans. Yet, their diagnostic use is hampered by the limited understanding of their biochemical or cellular origin and their frequently unclear link to the underlying diseases. Major advancements are expected from the analyses of human primary cells, cell lines and cultures of microorganisms. In this review, a database of 125 reliably identified VOCs previously reported for human healthy and diseased cells was assembled and their potential origin is discussed. The majority of them have also been observed in studies with other human matrices (breath, urine, saliva, feces, blood, skin emanations). Moreover, continuing improvements of qualitative and quantitative analyses, based on the recommendations of the ISO-11843 guidelines, are suggested for the necessary standardization of analytical procedures and better comparability of results. The data provided contribute to arriving at a more complete human volatilome and suggest potential volatile biomarkers for future validation.

KW - Biomarker

KW - Breath analysis

KW - Cancer

KW - GC-MS

KW - Human cell lines

KW - Standardization

KW - Volatile organic compounds (VOCS)

KW - Volatilome

UR - http://www.scopus.com/inward/record.url?scp=84983753514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983753514&partnerID=8YFLogxK

U2 - 10.2174/092986732366616031612505

DO - 10.2174/092986732366616031612505

M3 - Review article

VL - 23

SP - 2112

EP - 2131

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 20

ER -